Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid symbols : Bntx save search
Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
Published: 2022-03-15 (Crawled : 23:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 1.63%
H: 11.55%
C: 11.21%
covid-19 covid authorization vaccine tiona merge order emergency use authorization
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older
Published: 2022-01-03 (Crawled : 18:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.47%
H: 0.0%
C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.93%
H: 0.09%
C: -3.16%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.16%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -1.52%
H: 0.89%
C: -8.67%
covid-19 fda als covid authorization vaccine merge order emergency use authorization
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older
Published: 2021-12-09 (Crawled : 18:00) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: 0.69%
H: 0.68%
C: 0.68%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -3.53%
H: 0.32%
C: -4.65%
covid-19 fda covid authorization vaccine merge order emergency use authorization
Follow-Up Data from Phase 3 Trial Of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age
Published: 2021-11-22 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: -0.23%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -1.72%
H: 1.02%
C: 0.49%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 7.04%
H: 8.12%
C: 7.96%
covid vaccine phase 3 trial
Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older
Published: 2021-11-19 (Crawled : 13:30) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -2.67%
H: 0.45%
C: 0.45%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 3.28%
H: 0.0%
C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 1.58%
H: 0.0%
C: 0.0%
covid fda vaccine merge order emergency use authorization
Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine in Children Ages 5 Through 11 Years
Published: 2021-10-29 (Crawled : 22:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
| Email alert
Add to watchlist
covid fda children vaccine merge emergency use authorization
Pfizer and BioNTech to Provide U.S. Government an Additional 50 Million Pediatric Doses of COVID-19 Vaccine to Support Further Preparedness for Future Needs
Published: 2021-10-28 (Crawled : 12:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.05%
H: 1.68%
C: 0.54%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.83%
H: 1.2%
C: 0.32%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 1.34%
H: 2.2%
C: 0.52%
covid vaccine
FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech Covid-19 Vaccine in Children 5 to <12 Years
Published: 2021-10-26 (Crawled : 23:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.39%
H: 0.23%
C: -1.13%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.91%
H: 0.06%
C: -1.04%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.4%
H: 1.16%
C: -5.35%
covid fda children vaccine merge emergency use authorization
Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine
Published: 2021-10-21 (Crawled : 11:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.6%
H: 0.08%
C: -0.45%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.08%
H: 0.41%
C: 0.41%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 2.66%
H: 3.69%
C: 3.53%
covid vaccine phase 3 trial
Health Canada receives submission from Pfizer-BioNTech to authorize the use of Comirnaty COVID-19 vaccine in children 5 to 11 years of age
Published: 2021-10-18 (Crawled : 01:00) - biospace.com/
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.94%
H: 6.44%
C: 6.42%
covid children vaccine submission comirnaty®
Pfizer and BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine Booster in the European Union
Published: 2021-10-04 (Crawled : 17:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.54%
H: 0.77%
C: 0.17%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -7.79%
H: 7.42%
C: 5.95%
covid europe positive vaccine chmp covid-19
Pfizer and BioNTech Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to <12 Years of Age
Published: 2021-09-28 (Crawled : 12:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -1.15%
H: 0.49%
C: -0.07%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.15%
H: 0.06%
C: -0.6%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -4.36%
H: 1.09%
C: -5.85%
covid fda children vaccine trial
Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-For-Profit Price for Donation to Poorest Countries
Published: 2021-09-22 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.89%
H: 0.16%
C: -0.35%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.43%
H: 0.52%
C: -1.03%
covid collaboration vaccine
Pfizer and BioNTech Announce Positive Topline Results from Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years
Published: 2021-09-20 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.35%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -8.02%
H: 3.64%
C: -0.64%
covid positive results topline children vaccine trial
Scientists Rapidly Advancing Cancer Vaccine Prospects Using Same Technology as Covid-19 Shots
Published: 2021-09-17 (Crawled : 14:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: 0.31%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
covid cancer vaccine technology covid-19
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY Receives Full Health Canada Approval for Individuals 12 Years and Older
Published: 2021-09-16 (Crawled : 17:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.83%
H: 0.14%
C: -0.45%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -1.37%
H: 6.98%
C: 6.35%
covid canada approval vaccine approval comirnaty® order
Pfizer and BioNTech Announce Collaboration with Brazil’s Eurofarma to Manufacture COVID-19 Vaccine Doses for Latin America
Published: 2021-08-26 (Crawled : 11:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.4%
H: 0.96%
C: -0.67%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.37%
H: 0.19%
C: -0.25%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -1.34%
H: 1.78%
C: -0.27%
covid brazil collaboration vaccine announces collaboration
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older
Published: 2021-08-23 (Crawled : 16:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 3.22%
H: 2.13%
C: -0.72%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.28%
H: 0.09%
C: -0.59%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 7.12%
H: 3.88%
C: 2.3%
covid fda fda approval vaccine approval comirnaty® order
Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine
Published: 2021-08-16 (Crawled : 16:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 1.54%
H: 1.53%
C: 1.41%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.17%
H: 0.62%
C: 0.48%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -2.42%
H: 0.45%
C: -6.81%
covid fda vaccine submission
Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
Published: 2021-07-23 (Crawled : 13:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.02%
H: 0.89%
C: 0.53%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 2.15%
H: 1.85%
C: -1.77%
covid vaccine
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.